Roche: Andre Hoffmann, Patrick Frost, Anita Hauser, Jemilah Mahmood, More

Roche's shareholders have approved the re-election of all members of the board who stood for election, including Severin Schwan, André Hoffmann, Jörg Duschmalé, Patrick Frost, Anita Hauser, Akiko Iwasaki, Richard Lifton, Jemilah Mahmood, Mark Schneider, and Claudia Suessmuth Dyckerhoff. Schwan, who previously served as Roche's CEO from 2008 to 2023, was re-elected as chairman of the board. 

Hoffmann has been the vice-chairman of the board since 2006 and has served as a member since 1996. He previously served as special project manager at Nestlé UK.

Duschmalé is a fifth-generation descendant of Roche's founder and was a postdoctoral researcher in oligonucleotide chemistry at Roche from 2015 to 2018.

Frost has worked at life insurance company Swiss Life in Zurich since 2006, first as group chief information officer and then group CEO from 2014 to 2024. He previously served as the global head of fixed income investment at Winterthur Insurance.

Hauser is vice-chairwoman of the board of Bucher Industries. She was previously a managing director at Magenta Management and country manager and director at EF Education First. 

Iwasaki is a professor of immunobiology and molecular, cellular, and developmental biology at Yale University. She is also an investigator at the Howard Hughes Medical Institute, a nonprofit medical research organization.

Lifton is currently the president and the head of the Laboratory of Human Genetics and Genomics at the Rockefeller University, as well as an adjunct professor of genetics and internal medicine at Yale University. 

Mahmood is the executive director of Sunway Centre for Planetary Health at Sunway University. She was formerly the special advisor on public health to Malaysia's prime minister and the undersecretary general for partnerships at the International Federation of Red Cross and Red Crescent Societies.

Schneider served as CEO of Nestlé from 2017 to 2024 and was previously CEO of the Fresenius Group, a German healthcare company.

Dyckerhoff is a senior external advisor for McKinsey & Company, which she has worked at since 1995. She has previously served in many roles, including as sector leader for Asia Health Services and Systems.